Foghorn Therapeutics Inc. (FHTX)
Drugs • Health Care
Percentage
Change
| Mar 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|
Total Assets | 284 | 198 | ||||
Current Assets | 250 | 163 | ||||
Cash and Equivalents and Short-term Investments | 244 | 159 | ||||
Cash & Equivalents | 55 | 81 | ||||
Short-term Investments | 188 | 78 | ||||
Restricted Cash & Investments | 0 | 1 | ||||
Prepaid Expenses | 6 | 3 | ||||
Total Non-current Assets | 34 | 35 | ||||
Net Property, Plant & Equipment | 10 | 2 | ||||
Lease Assets | 23 | 31 | ||||
Other Non-current Assets | 2 | 2 |
| Mar 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|
Total Liabilities and Equity | 284 | 198 | ||||
Total Equity and Non-controlling Interests | -46 | -109 | ||||
Total Equity | -46 | -109 | ||||
Total Common Stock | 0 | 0 | ||||
Additional Paid-in Capital | 513 | 524 | ||||
Retained Earnings | -558 | -633 | ||||
Other Equity | 0 | 0 | ||||
Total Liabilities | 330 | 307 | ||||
Total Current Liabilities | 67 | 60 | ||||
Account Payable & Accrued Liabilities | 4 | 4 | ||||
Current Debt | 9 | 1 | ||||
Current Deferred Revenue | 46 | 43 | ||||
Other Current Liabilities | 9 | 11 | ||||
Total Non-current Liabilities | 263 | 247 | ||||
Non-current Deferred Revenue | 234 | 206 | ||||
Other Non-current Liabilities | 28 | 41 |